Showing results (431-440 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|May 10, 2014
Respiratory syncytial virus: current and emerging treatment optionsTiffany L Turner, Benjamin T Kopp, Grace Paul, et al.
Clinicoeconomics and Outcomes Research : CEOR|March 18, 2021
The Trend of Direct Medical Cost of Meliodiosis Patients in Kedah: A Retrospective Study from 2014 to 2017Kamaruddin Mardhiah, Nadiah Wan-Arfah, Nyi Nyi Naing, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 10, 2021
Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use DisorderFulton F Velez, Sam Colman, Laura Kauffman, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 29, 2014
Cost-effectiveness analysis of Mammostrat® compared with Oncotype DX® to inform the treatment of breast cancerKimberly Mislick, Warren Schonfeld, Carolyn Bodnar, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 10, 2022
Substantial Out-of-Pocket Health Expenditure on Prenatal Check-Ups: Estimates from a Sample of Pregnant Women in Cartagena, ColombiaNelson J Alvis-Zakzuk, Diana Díaz-Jiménez, Pablo Chaparro-Narváez, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 10, 2022
Cost-Utility Analysis of Molecular Testing for Tuberculosis Diagnosis in Suspected Pulmonary Tuberculosis in ThailandNatthakan Chitpim, Jiraphun Jittikoon, Wanvisa Udomsinprasert, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 14, 2012
Cost of human immunodeficiency virus infection in Italy, 2007-2009: effective and expensive, are the new drugs worthwhile?Giuliano Rizzardini, Umberto Restelli, Paolo Bonfanti, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 30, 2012
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infectionPaolo Sacchi, Savino Fa Patruno, Raffaele Bruno, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 25, 2012
State of health economic evaluation research in Saudi Arabia: a reviewSinaa A Al-Aqeel
Clinicoeconomics and Outcomes Research : CEOR|January 23, 2015
End-stage renal disease in autosomal dominant polycystic kidney disease: a comparison of dialysis-related utilization and costs with other chronic kidney diseasesSteven M Brunelli, Christopher M Blanchette, Ami J Claxton, et al.
Pageof 102